Tags : iscalimab

Novartis Reports Histology Data of CFZ533 (iscalimab) in Kidney Transplantation

Shots: The study involves assessing of calcineurin-free treatment with iscalimab vs tacrolimus to test the durability of transplanted kidney grafts and improve long-term outcomes for kidney transplant patients The study resulted in 60% normal kidney histology@1 year for iscalimab-treated transplant patients with lower chronic allograft damage index (CADI) scores, Presented at American Transplant Congress (ATC) […]Read More